位置:首页 > 蛋白库 > CD79A_HUMAN
CD79A_HUMAN
ID   CD79A_HUMAN             Reviewed;         226 AA.
AC   P11912; A0N775; Q53FB8;
DT   01-OCT-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 2.
DT   03-AUG-2022, entry version 202.
DE   RecName: Full=B-cell antigen receptor complex-associated protein alpha chain;
DE   AltName: Full=Ig-alpha;
DE   AltName: Full=MB-1 membrane glycoprotein;
DE   AltName: Full=Membrane-bound immunoglobulin-associated protein;
DE   AltName: Full=Surface IgM-associated protein;
DE   AltName: CD_antigen=CD79a;
DE   Flags: Precursor;
GN   Name=CD79A; Synonyms=IGA, MB1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1395095; DOI=10.1111/j.1365-2249.1992.tb05846.x;
RA   Leduc I., Preud'Homme J.L., Cogne M.;
RT   "Structure and expression of the mb-1 transcript in human lymphoid cells.";
RL   Clin. Exp. Immunol. 90:141-146(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Tonsil;
RX   PubMed=1534761; DOI=10.1002/eji.1830220641;
RA   Mueller B.S., Cooper L., Terhorst C.;
RT   "Cloning and sequencing of the cDNA encoding the human homologue of the
RT   murine immunoglobulin-associated protein B29.";
RL   Eur. J. Immunol. 22:1621-1625(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1639443; DOI=10.1007/bf00215058;
RA   Flaswinkel H., Reth M.;
RT   "Molecular cloning of the Ig-alpha subunit of the human B-cell antigen
RT   receptor complex.";
RL   Immunogenetics 36:266-269(1992).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1729378;
RA   Yu L.M., Chang T.W.;
RT   "Human mb-1 gene: complete cDNA sequence and its expression in B cells
RT   bearing membrane Ig of various isotypes.";
RL   J. Immunol. 148:633-637(1992).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1).
RX   PubMed=1538135;
RA   Ha H.J., Kubagawa H., Burrows P.D.;
RT   "Molecular cloning and expression pattern of a human gene homologous to the
RT   murine mb-1 gene.";
RL   J. Immunol. 148:1526-1531(1992).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=7916003; DOI=10.1007/bf00189974;
RA   Hashimoto S., Mohrenweiser H.W., Gregersen P.K., Chiorazzi N.;
RT   "Chromosomal localization, genomic structure, and allelic polymorphism of
RT   the human CD79 alpha (Ig-alpha/mb-1) gene.";
RL   Immunogenetics 40:287-295(1994).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8207205;
RA   Ha H., Barnoski B.L., Sun L., Emanuel B.S., Burrows P.D.;
RT   "Structure, chromosomal localization, and methylation pattern of the human
RT   mb-1 gene.";
RL   J. Immunol. 152:5749-5757(1994).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=7643857; DOI=10.1016/0161-5890(95)00023-8;
RA   Hashimoto S., Chiorazzi N., Gregersen P.K.;
RT   "Alternative splicing of CD79a (Ig-alpha/mb-1) and CD79b (Ig-beta/B29) RNA
RT   transcripts in human B cells.";
RL   Mol. Immunol. 32:651-659(1995).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RA   Koyama M., Nakamura T.;
RL   Submitted (DEC-1994) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Small intestine;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   PROTEIN SEQUENCE OF 33-52.
RX   PubMed=7514267; DOI=10.1016/0161-5890(94)90061-2;
RA   Vasile S., Coligan J.E., Yoshida M., Seon B.K.;
RT   "Isolation and chemical characterization of the human B29 and mb-1 proteins
RT   of the B cell antigen receptor complex.";
RL   Mol. Immunol. 31:419-427(1994).
RN   [12]
RP   PRELIMINARY NUCLEOTIDE SEQUENCE [MRNA] OF 190-226 (ISOFORM 1).
RX   PubMed=2463161; DOI=10.1002/j.1460-2075.1988.tb03220.x;
RA   Sakaguchi N., Kashiwamura S., Kimoto M., Thalmann P., Melchers F.;
RT   "B lymphocyte lineage-restricted expression of mb-1, a gene with CD3-like
RT   structural properties.";
RL   EMBO J. 7:3457-3464(1988).
RN   [13]
RP   FUNCTION.
RX   PubMed=8617796; DOI=10.1074/jbc.271.9.5158;
RA   Luisiri P., Lee Y.J., Eisfelder B.J., Clark M.R.;
RT   "Cooperativity and segregation of function within the Ig-alpha/beta
RT   heterodimer of the B cell antigen receptor complex.";
RL   J. Biol. Chem. 271:5158-5163(1996).
RN   [14]
RP   FUNCTION.
RX   PubMed=9057631;
RA   Tseng J., Eisfelder B.J., Clark M.R.;
RT   "B-cell antigen receptor-induced apoptosis requires both Ig alpha and Ig
RT   beta.";
RL   Blood 89:1513-1520(1997).
RN   [15]
RP   INVOLVEMENT IN AGM3.
RX   PubMed=10525050; DOI=10.1172/jci7696;
RA   Minegishi Y., Coustan-Smith E., Rapalus L., Ersoy F., Campana D.,
RA   Conley M.E.;
RT   "Mutations in Igalpha (CD79a) result in a complete block in B-cell
RT   development.";
RL   J. Clin. Invest. 104:1115-1121(1999).
RN   [16]
RP   PHOSPHORYLATION, AND MUTAGENESIS OF SER-197; SER-203 AND THR-209.
RX   PubMed=10900006; DOI=10.1073/pnas.97.15.8451;
RA   Mueller R., Wienands J., Reth M.;
RT   "The serine and threonine residues in the Ig-alpha cytoplasmic tail
RT   negatively regulate immunoreceptor tyrosine-based activation motif-mediated
RT   signal transduction.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:8451-8454(2000).
RN   [17]
RP   INVOLVEMENT IN AGM3.
RX   PubMed=11920841; DOI=10.1002/ajmg.10296;
RA   Wang Y., Kanegane H., Sanal O., Tezcan I., Ersoy F., Futatani T.,
RA   Miyawaki T.;
RT   "Novel Igalpha (CD79a) gene mutation in a Turkish patient with B cell-
RT   deficient agammaglobulinemia.";
RL   Am. J. Med. Genet. 108:333-336(2002).
RN   [18]
RP   STRUCTURE BY NMR OF 184-195, PHOSPHORYLATION, AND INTERACTION WITH LYN.
RX   PubMed=10748115; DOI=10.1074/jbc.m909044199;
RA   Gaul B.S., Harrison M.L., Geahlen R.L., Burton R.A., Post C.B.;
RT   "Substrate recognition by the Lyn protein-tyrosine kinase. NMR structure of
RT   the immunoreceptor tyrosine-based activation motif signaling region of the
RT   B cell antigen receptor.";
RL   J. Biol. Chem. 275:16174-16182(2000).
CC   -!- FUNCTION: Required in cooperation with CD79B for initiation of the
CC       signal transduction cascade activated by binding of antigen to the B-
CC       cell antigen receptor complex (BCR) which leads to internalization of
CC       the complex, trafficking to late endosomes and antigen presentation.
CC       Also required for BCR surface expression and for efficient
CC       differentiation of pro- and pre-B-cells. Stimulates SYK
CC       autophosphorylation and activation. Binds to BLNK, bringing BLNK into
CC       proximity with SYK and allowing SYK to phosphorylate BLNK. Also
CC       interacts with and increases activity of some Src-family tyrosine
CC       kinases. Represses BCR signaling during development of immature B-
CC       cells. {ECO:0000269|PubMed:8617796, ECO:0000269|PubMed:9057631}.
CC   -!- SUBUNIT: Heterodimer of alpha and beta chains; disulfide-linked. Part
CC       of the B-cell antigen receptor complex where the alpha/beta chain
CC       heterodimer is non-covalently associated with an antigen-specific
CC       membrane-bound surface immunoglobulin of two heavy chains and two light
CC       chains. Interacts through its phosphorylated ITAM domain with the SH2
CC       domains of SYK which stimulates SYK autophosphorylation and activation.
CC       Also interacts, when phosphorylated on Tyr-210, with the SH2 domain of
CC       BLNK/SLP65, bringing BLNK into proximity with SYK and allowing SYK to
CC       phosphorylate BLNK which is necessary for trafficking of the BCR to
CC       late endosomes. Interacts with Src-family tyrosine kinases including
CC       FYN and LYN, increasing their activity (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       P11912; Q15848: ADIPOQ; NbExp=3; IntAct=EBI-7797864, EBI-10827839;
CC       P11912; Q6RW13-2: AGTRAP; NbExp=3; IntAct=EBI-7797864, EBI-11522760;
CC       P11912; Q5BKT4: ALG10; NbExp=3; IntAct=EBI-7797864, EBI-13064220;
CC       P11912; Q5I7T1: ALG10B; NbExp=3; IntAct=EBI-7797864, EBI-18075734;
CC       P11912; Q92685: ALG3; NbExp=3; IntAct=EBI-7797864, EBI-2848814;
CC       P11912; P05090: APOD; NbExp=3; IntAct=EBI-7797864, EBI-715495;
CC       P11912; P29972: AQP1; NbExp=3; IntAct=EBI-7797864, EBI-745213;
CC       P11912; Q92482: AQP3; NbExp=3; IntAct=EBI-7797864, EBI-2808854;
CC       P11912; P27449: ATP6V0C; NbExp=3; IntAct=EBI-7797864, EBI-721179;
CC       P11912; Q92843: BCL2L2; NbExp=3; IntAct=EBI-7797864, EBI-707714;
CC       P11912; O15155: BET1; NbExp=3; IntAct=EBI-7797864, EBI-749204;
CC       P11912; Q6PL45-2: BRICD5; NbExp=3; IntAct=EBI-7797864, EBI-12244618;
CC       P11912; Q8WVV5: BTN2A2; NbExp=3; IntAct=EBI-7797864, EBI-8648738;
CC       P11912; O14523: C2CD2L; NbExp=3; IntAct=EBI-7797864, EBI-12822627;
CC       P11912; Q8WVX3-2: C4orf3; NbExp=3; IntAct=EBI-7797864, EBI-12003442;
CC       P11912; Q9P0B6: CCDC167; NbExp=3; IntAct=EBI-7797864, EBI-9083477;
CC       P11912; O14735: CDIPT; NbExp=3; IntAct=EBI-7797864, EBI-358858;
CC       P11912; O95832: CLDN1; NbExp=3; IntAct=EBI-7797864, EBI-723889;
CC       P11912; Q9NWW5: CLN6; NbExp=3; IntAct=EBI-7797864, EBI-6165897;
CC       P11912; Q96DZ9-2: CMTM5; NbExp=3; IntAct=EBI-7797864, EBI-11522780;
CC       P11912; Q96FZ5: CMTM7; NbExp=3; IntAct=EBI-7797864, EBI-2807956;
CC       P11912; O95406: CNIH1; NbExp=3; IntAct=EBI-7797864, EBI-12172273;
CC       P11912; Q8TBE1: CNIH3; NbExp=3; IntAct=EBI-7797864, EBI-12208021;
CC       P11912; P29400-2: COL4A5; NbExp=3; IntAct=EBI-7797864, EBI-12211159;
CC       P11912; Q4LDR2: CTXN3; NbExp=3; IntAct=EBI-7797864, EBI-12019274;
CC       P11912; P49447: CYB561; NbExp=3; IntAct=EBI-7797864, EBI-8646596;
CC       P11912; Q8NBI2: CYB561A3; NbExp=3; IntAct=EBI-7797864, EBI-10269179;
CC       P11912; O14569: CYB561D2; NbExp=3; IntAct=EBI-7797864, EBI-717654;
CC       P11912; O43169: CYB5B; NbExp=3; IntAct=EBI-7797864, EBI-1058710;
CC       P11912; Q9H1M4: DEFB127; NbExp=3; IntAct=EBI-7797864, EBI-10305240;
CC       P11912; Q9UPQ8: DOLK; NbExp=3; IntAct=EBI-7797864, EBI-8645574;
CC       P11912; P56851: EDDM3B; NbExp=3; IntAct=EBI-7797864, EBI-10215665;
CC       P11912; Q9BV81: EMC6; NbExp=3; IntAct=EBI-7797864, EBI-2820492;
CC       P11912; P54849: EMP1; NbExp=3; IntAct=EBI-7797864, EBI-4319440;
CC       P11912; P54852: EMP3; NbExp=3; IntAct=EBI-7797864, EBI-3907816;
CC       P11912; Q7L5A8: FA2H; NbExp=3; IntAct=EBI-7797864, EBI-11337888;
CC       P11912; Q96D05-2: FAM241B; NbExp=3; IntAct=EBI-7797864, EBI-12118888;
CC       P11912; Q969F0: FATE1; NbExp=6; IntAct=EBI-7797864, EBI-743099;
CC       P11912; Q96IV6: FAXDC2; NbExp=3; IntAct=EBI-7797864, EBI-12142299;
CC       P11912; P37268: FDFT1; NbExp=3; IntAct=EBI-7797864, EBI-714550;
CC       P11912; O14843: FFAR3; NbExp=3; IntAct=EBI-7797864, EBI-17762181;
CC       P11912; Q14318: FKBP8; NbExp=3; IntAct=EBI-7797864, EBI-724839;
CC       P11912; Q9BWH2: FUNDC2; NbExp=3; IntAct=EBI-7797864, EBI-714482;
CC       P11912; Q14802-3: FXYD3; NbExp=3; IntAct=EBI-7797864, EBI-12175685;
CC       P11912; Q8N3T1: GALNT15; NbExp=3; IntAct=EBI-7797864, EBI-3925203;
CC       P11912; Q8WWP7: GIMAP1; NbExp=3; IntAct=EBI-7797864, EBI-11991950;
CC       P11912; P08034: GJB1; NbExp=3; IntAct=EBI-7797864, EBI-17565645;
CC       P11912; O15529: GPR42; NbExp=3; IntAct=EBI-7797864, EBI-18076404;
CC       P11912; Q5VWC8: HACD4; NbExp=3; IntAct=EBI-7797864, EBI-18076069;
CC       P11912; P09601: HMOX1; NbExp=3; IntAct=EBI-7797864, EBI-2806151;
CC       P11912; P30519: HMOX2; NbExp=3; IntAct=EBI-7797864, EBI-712096;
CC       P11912; P46695: IER3; NbExp=3; IntAct=EBI-7797864, EBI-1748945;
CC       P11912; Q9Y5U4: INSIG2; NbExp=3; IntAct=EBI-7797864, EBI-8503746;
CC       P11912; P11215: ITGAM; NbExp=3; IntAct=EBI-7797864, EBI-2568251;
CC       P11912; Q8N5M9: JAGN1; NbExp=3; IntAct=EBI-7797864, EBI-10266796;
CC       P11912; P07942: LAMB1; NbExp=3; IntAct=EBI-7797864, EBI-949174;
CC       P11912; O95214: LEPROTL1; NbExp=3; IntAct=EBI-7797864, EBI-750776;
CC       P11912; Q8TAF8: LHFPL5; NbExp=3; IntAct=EBI-7797864, EBI-2820517;
CC       P11912; Q9UBY5: LPAR3; NbExp=3; IntAct=EBI-7797864, EBI-12033434;
CC       P11912; Q16873: LTC4S; NbExp=3; IntAct=EBI-7797864, EBI-12241118;
CC       P11912; Q13021: MALL; NbExp=3; IntAct=EBI-7797864, EBI-750078;
CC       P11912; Q9P0N8: MARCHF2; NbExp=3; IntAct=EBI-7797864, EBI-10317612;
CC       P11912; Q9GZY8-5: MFF; NbExp=3; IntAct=EBI-7797864, EBI-11956541;
CC       P11912; Q6NUT3-2: MFSD12; NbExp=3; IntAct=EBI-7797864, EBI-17295698;
CC       P11912; Q6N075: MFSD5; NbExp=3; IntAct=EBI-7797864, EBI-3920969;
CC       P11912; Q6ZSS7: MFSD6; NbExp=3; IntAct=EBI-7797864, EBI-2858252;
CC       P11912; A0A0C4DFN3: MGLL; NbExp=3; IntAct=EBI-7797864, EBI-12866138;
CC       P11912; Q8IY49-2: MMD2; NbExp=3; IntAct=EBI-7797864, EBI-13349813;
CC       P11912; O75425: MOSPD3; NbExp=3; IntAct=EBI-7797864, EBI-12179105;
CC       P11912; Q5J8X5: MS4A13; NbExp=3; IntAct=EBI-7797864, EBI-12070086;
CC       P11912; Q96S97: MYADM; NbExp=3; IntAct=EBI-7797864, EBI-13301517;
CC       P11912; A6NDP7: MYADML2; NbExp=3; IntAct=EBI-7797864, EBI-17641390;
CC       P11912; Q9UHE5: NAT8; NbExp=3; IntAct=EBI-7797864, EBI-2863634;
CC       P11912; Q99519: NEU1; NbExp=3; IntAct=EBI-7797864, EBI-721517;
CC       P11912; Q9NZG7: NINJ2; NbExp=3; IntAct=EBI-7797864, EBI-10317425;
CC       P11912; Q6P499: NIPAL3; NbExp=3; IntAct=EBI-7797864, EBI-10252783;
CC       P11912; Q16617: NKG7; NbExp=3; IntAct=EBI-7797864, EBI-3919611;
CC       P11912; Q8N912: NRAC; NbExp=3; IntAct=EBI-7797864, EBI-12051377;
CC       P11912; Q53FV1: ORMDL2; NbExp=3; IntAct=EBI-7797864, EBI-11075081;
CC       P11912; Q7RTS6: OTOP2; NbExp=3; IntAct=EBI-7797864, EBI-7642372;
CC       P11912; Q9UHJ9-5: PGAP2; NbExp=3; IntAct=EBI-7797864, EBI-12092917;
CC       P11912; Q99640-2: PKMYT1; NbExp=3; IntAct=EBI-7797864, EBI-12257782;
CC       P11912; Q04941: PLP2; NbExp=3; IntAct=EBI-7797864, EBI-608347;
CC       P11912; Q8IY26: PLPP6; NbExp=3; IntAct=EBI-7797864, EBI-11721828;
CC       P11912; Q96GM1: PLPPR2; NbExp=3; IntAct=EBI-7797864, EBI-12955265;
CC       P11912; P54315: PNLIPRP1; NbExp=3; IntAct=EBI-7797864, EBI-8652812;
CC       P11912; Q59EV6: PPGB; NbExp=3; IntAct=EBI-7797864, EBI-14210385;
CC       P11912; O60831: PRAF2; NbExp=3; IntAct=EBI-7797864, EBI-2506064;
CC       P11912; Q13635-3: PTCH1; NbExp=3; IntAct=EBI-7797864, EBI-14199621;
CC       P11912; Q96HR9-2: REEP6; NbExp=3; IntAct=EBI-7797864, EBI-14065960;
CC       P11912; P08100: RHO; NbExp=3; IntAct=EBI-7797864, EBI-1394177;
CC       P11912; Q5QGT7: RTP2; NbExp=3; IntAct=EBI-7797864, EBI-10244780;
CC       P11912; Q9NTJ5: SACM1L; NbExp=3; IntAct=EBI-7797864, EBI-3917235;
CC       P11912; O75396: SEC22B; NbExp=3; IntAct=EBI-7797864, EBI-1058865;
CC       P11912; Q9Y6X1: SERP1; NbExp=3; IntAct=EBI-7797864, EBI-10329948;
CC       P11912; P11686: SFTPC; NbExp=3; IntAct=EBI-7797864, EBI-10197617;
CC       P11912; Q9UKG4: SLC13A4; NbExp=6; IntAct=EBI-7797864, EBI-12808018;
CC       P11912; Q86YT5: SLC13A5; NbExp=3; IntAct=EBI-7797864, EBI-12002412;
CC       P11912; Q6ZSM3: SLC16A12; NbExp=3; IntAct=EBI-7797864, EBI-17460560;
CC       P11912; Q7RTY0: SLC16A13; NbExp=3; IntAct=EBI-7797864, EBI-12243266;
CC       P11912; Q9BRI3: SLC30A2; NbExp=3; IntAct=EBI-7797864, EBI-8644112;
CC       P11912; P78383: SLC35B1; NbExp=3; IntAct=EBI-7797864, EBI-12147661;
CC       P11912; Q969S0: SLC35B4; NbExp=3; IntAct=EBI-7797864, EBI-10281213;
CC       P11912; Q9H2H9: SLC38A1; NbExp=6; IntAct=EBI-7797864, EBI-9978441;
CC       P11912; Q9NP94: SLC39A2; NbExp=3; IntAct=EBI-7797864, EBI-12898013;
CC       P11912; Q9NUM3: SLC39A9; NbExp=3; IntAct=EBI-7797864, EBI-2823239;
CC       P11912; Q8IVJ1: SLC41A1; NbExp=3; IntAct=EBI-7797864, EBI-12266234;
CC       P11912; Q96JW4: SLC41A2; NbExp=3; IntAct=EBI-7797864, EBI-10290130;
CC       P11912; Q7Z3Q1-2: SLC46A3; NbExp=3; IntAct=EBI-7797864, EBI-18074862;
CC       P11912; Q8N2U9: SLC66A2; NbExp=3; IntAct=EBI-7797864, EBI-3907610;
CC       P11912; P48065: SLC6A12; NbExp=3; IntAct=EBI-7797864, EBI-3843589;
CC       P11912; P30825: SLC7A1; NbExp=3; IntAct=EBI-7797864, EBI-4289564;
CC       P11912; Q9NRQ5: SMCO4; NbExp=3; IntAct=EBI-7797864, EBI-8640191;
CC       P11912; Q9BZL3: SMIM3; NbExp=3; IntAct=EBI-7797864, EBI-741850;
CC       P11912; P0DN84: STRIT1; NbExp=3; IntAct=EBI-7797864, EBI-12200293;
CC       P11912; Q86Y82: STX12; NbExp=3; IntAct=EBI-7797864, EBI-2691717;
CC       P11912; Q13277: STX3; NbExp=3; IntAct=EBI-7797864, EBI-1394295;
CC       P11912; Q9UNK0: STX8; NbExp=3; IntAct=EBI-7797864, EBI-727240;
CC       P11912; P57105: SYNJ2BP; NbExp=3; IntAct=EBI-7797864, EBI-1049004;
CC       P11912; Q9NZ01: TECR; NbExp=3; IntAct=EBI-7797864, EBI-2877718;
CC       P11912; P07204: THBD; NbExp=3; IntAct=EBI-7797864, EBI-941422;
CC       P11912; Q96DZ7: TM4SF19; NbExp=3; IntAct=EBI-7797864, EBI-6448756;
CC       P11912; P48230: TM4SF4; NbExp=3; IntAct=EBI-7797864, EBI-8650934;
CC       P11912; P55061: TMBIM6; NbExp=3; IntAct=EBI-7797864, EBI-1045825;
CC       P11912; Q6UX40: TMEM107; NbExp=3; IntAct=EBI-7797864, EBI-12845616;
CC       P11912; P17152: TMEM11; NbExp=3; IntAct=EBI-7797864, EBI-723946;
CC       P11912; Q5BJH2-2: TMEM128; NbExp=3; IntAct=EBI-7797864, EBI-10694905;
CC       P11912; Q9NV12: TMEM140; NbExp=3; IntAct=EBI-7797864, EBI-2844246;
CC       P11912; Q9BVK8: TMEM147; NbExp=3; IntAct=EBI-7797864, EBI-348587;
CC       P11912; Q9NUH8: TMEM14B; NbExp=3; IntAct=EBI-7797864, EBI-8638294;
CC       P11912; Q96HP8: TMEM176A; NbExp=3; IntAct=EBI-7797864, EBI-2800645;
CC       P11912; Q14656: TMEM187; NbExp=3; IntAct=EBI-7797864, EBI-13046724;
CC       P11912; Q96HH6: TMEM19; NbExp=3; IntAct=EBI-7797864, EBI-741829;
CC       P11912; A2RU14: TMEM218; NbExp=3; IntAct=EBI-7797864, EBI-10173151;
CC       P11912; Q9H0R3: TMEM222; NbExp=3; IntAct=EBI-7797864, EBI-347385;
CC       P11912; Q8NBD8: TMEM229B; NbExp=3; IntAct=EBI-7797864, EBI-12195227;
CC       P11912; Q8WW34-2: TMEM239; NbExp=3; IntAct=EBI-7797864, EBI-11528917;
CC       P11912; Q9BU79: TMEM243; NbExp=3; IntAct=EBI-7797864, EBI-12887458;
CC       P11912; Q8TBM7: TMEM254; NbExp=3; IntAct=EBI-7797864, EBI-11956809;
CC       P11912; E9PQX1: TMEM262; NbExp=3; IntAct=EBI-7797864, EBI-17180389;
CC       P11912; Q69YG0: TMEM42; NbExp=3; IntAct=EBI-7797864, EBI-12038591;
CC       P11912; Q8N2M4: TMEM86A; NbExp=3; IntAct=EBI-7797864, EBI-12015604;
CC       P11912; Q8N661: TMEM86B; NbExp=3; IntAct=EBI-7797864, EBI-2548832;
CC       P11912; Q6ZT21: TMPPE; NbExp=3; IntAct=EBI-7797864, EBI-11724433;
CC       P11912; O14798: TNFRSF10C; NbExp=3; IntAct=EBI-7797864, EBI-717441;
CC       P11912; Q8N609: TRAM1L1; NbExp=3; IntAct=EBI-7797864, EBI-11996766;
CC       P11912; A0AVG3: TSNARE1; NbExp=3; IntAct=EBI-7797864, EBI-12003468;
CC       P11912; O60636: TSPAN2; NbExp=3; IntAct=EBI-7797864, EBI-3914288;
CC       P11912; Q5TGU0: TSPO2; NbExp=3; IntAct=EBI-7797864, EBI-12195249;
CC       P11912; A5PKU2: TUSC5; NbExp=3; IntAct=EBI-7797864, EBI-11988865;
CC       P11912; Q9Y385: UBE2J1; NbExp=3; IntAct=EBI-7797864, EBI-988826;
CC       P11912; Q9Y5Z9: UBIAD1; NbExp=3; IntAct=EBI-7797864, EBI-2819725;
CC       P11912; Q9H1C4: UNC93B1; NbExp=3; IntAct=EBI-7797864, EBI-4401271;
CC       P11912; Q15836: VAMP3; NbExp=3; IntAct=EBI-7797864, EBI-722343;
CC       P11912; Q9P0L0: VAPA; NbExp=3; IntAct=EBI-7797864, EBI-1059156;
CC       P11912; O95292: VAPB; NbExp=3; IntAct=EBI-7797864, EBI-1188298;
CC       P11912; Q9UEU0: VTI1B; NbExp=3; IntAct=EBI-7797864, EBI-723716;
CC       P11912; Q14508: WFDC2; NbExp=3; IntAct=EBI-7797864, EBI-723529;
CC       P11912; O76024: WFS1; NbExp=3; IntAct=EBI-7797864, EBI-720609;
CC       P11912; O95070: YIF1A; NbExp=3; IntAct=EBI-7797864, EBI-2799703;
CC       P11912; Q9BSR8: YIPF4; NbExp=3; IntAct=EBI-7797864, EBI-751253;
CC       P11912; Q96EC8: YIPF6; NbExp=3; IntAct=EBI-7797864, EBI-751210;
CC       P11912; Q96MV8: ZDHHC15; NbExp=3; IntAct=EBI-7797864, EBI-12837904;
CC       P11912; Q8N966: ZDHHC22; NbExp=3; IntAct=EBI-7797864, EBI-10268111;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein. Note=Following antigen binding, the BCR has been shown to
CC       translocate from detergent-soluble regions of the cell membrane to
CC       lipid rafts although signal transduction through the complex can also
CC       occur outside lipid rafts. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=Long;
CC         IsoId=P11912-1; Sequence=Displayed;
CC       Name=2; Synonyms=Short;
CC         IsoId=P11912-2; Sequence=VSP_002476;
CC   -!- TISSUE SPECIFICITY: B-cells.
CC   -!- PTM: Phosphorylated on tyrosine, serine and threonine residues upon B-
CC       cell activation. Phosphorylation of tyrosine residues by Src-family
CC       kinases is an early and essential feature of the BCR signaling cascade.
CC       The phosphorylated tyrosines serve as docking sites for SH2-domain
CC       containing kinases, leading to their activation which in turn leads to
CC       phosphorylation of downstream targets. Phosphorylated by LYN.
CC       Phosphorylation of serine and threonine residues may prevent subsequent
CC       tyrosine phosphorylation. {ECO:0000269|PubMed:10748115,
CC       ECO:0000269|PubMed:10900006}.
CC   -!- PTM: Arginine methylation in the ITAM domain may interfere with the
CC       binding of SYK. It promotes signals leading to B-cell differentiation
CC       (By similarity). {ECO:0000250}.
CC   -!- DISEASE: Agammaglobulinemia 3, autosomal recessive (AGM3) [MIM:613501]:
CC       A primary immunodeficiency characterized by profoundly low or absent
CC       serum antibodies and low or absent circulating B-cells due to an early
CC       block of B-cell development. Affected individuals develop severe
CC       infections in the first years of life. {ECO:0000269|PubMed:10525050,
CC       ECO:0000269|PubMed:11920841}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry. Two different mutations,
CC       one at the splice donor site of intron 2 and the other at the splice
CC       acceptor site for exon 3, have been identified. Both mutations give
CC       rise to a truncated protein.
CC   -!- WEB RESOURCE: Name=CD79Abase; Note=CD79A mutation db;
CC       URL="http://structure.bmc.lu.se/idbase/CD79Abase/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; S46706; AAB23558.1; -; mRNA.
DR   EMBL; M80462; AAA59556.1; -; mRNA.
DR   EMBL; M74721; AAA60270.1; -; mRNA.
DR   EMBL; S75217; AAB20812.1; -; mRNA.
DR   EMBL; M86921; AAA59557.1; -; mRNA.
DR   EMBL; U05259; AAA20495.1; -; Genomic_DNA.
DR   EMBL; S79248; AAC60653.1; -; mRNA.
DR   EMBL; X83540; CAA58523.1; -; mRNA.
DR   EMBL; AK223371; BAD97091.1; -; mRNA.
DR   EMBL; X13451; CAA31802.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS12589.1; -. [P11912-1]
DR   CCDS; CCDS46088.1; -. [P11912-2]
DR   PIR; I54539; A46477.
DR   PIR; S12504; S12504.
DR   RefSeq; NP_001774.1; NM_001783.3. [P11912-1]
DR   RefSeq; NP_067612.1; NM_021601.3. [P11912-2]
DR   PDB; 1CV9; NMR; -; A=184-195.
DR   PDBsum; 1CV9; -.
DR   AlphaFoldDB; P11912; -.
DR   BMRB; P11912; -.
DR   SMR; P11912; -.
DR   BioGRID; 107411; 241.
DR   ELM; P11912; -.
DR   IntAct; P11912; 198.
DR   MINT; P11912; -.
DR   STRING; 9606.ENSP00000221972; -.
DR   GlyConnect; 1028; 1 N-Linked glycan (1 site).
DR   GlyGen; P11912; 9 sites, 1 N-linked glycan (1 site).
DR   iPTMnet; P11912; -.
DR   PhosphoSitePlus; P11912; -.
DR   BioMuta; CD79A; -.
DR   DMDM; 547896; -.
DR   CPTAC; CPTAC-1178; -.
DR   EPD; P11912; -.
DR   MassIVE; P11912; -.
DR   MaxQB; P11912; -.
DR   PaxDb; P11912; -.
DR   PeptideAtlas; P11912; -.
DR   PRIDE; P11912; -.
DR   ProteomicsDB; 52811; -. [P11912-1]
DR   ProteomicsDB; 52812; -. [P11912-2]
DR   Antibodypedia; 2990; 2240 antibodies from 47 providers.
DR   DNASU; 973; -.
DR   Ensembl; ENST00000221972.8; ENSP00000221972.3; ENSG00000105369.10. [P11912-1]
DR   Ensembl; ENST00000444740.2; ENSP00000400605.1; ENSG00000105369.10. [P11912-2]
DR   GeneID; 973; -.
DR   KEGG; hsa:973; -.
DR   MANE-Select; ENST00000221972.8; ENSP00000221972.3; NM_001783.4; NP_001774.1.
DR   UCSC; uc002oru.4; human. [P11912-1]
DR   CTD; 973; -.
DR   DisGeNET; 973; -.
DR   GeneCards; CD79A; -.
DR   HGNC; HGNC:1698; CD79A.
DR   HPA; ENSG00000105369; Group enriched (intestine, lymphoid tissue).
DR   MalaCards; CD79A; -.
DR   MIM; 112205; gene.
DR   MIM; 613501; phenotype.
DR   neXtProt; NX_P11912; -.
DR   OpenTargets; ENSG00000105369; -.
DR   Orphanet; 33110; Autosomal agammaglobulinemia.
DR   PharmGKB; PA26237; -.
DR   VEuPathDB; HostDB:ENSG00000105369; -.
DR   eggNOG; ENOG502S1DI; Eukaryota.
DR   GeneTree; ENSGT00940000154363; -.
DR   HOGENOM; CLU_106774_0_0_1; -.
DR   InParanoid; P11912; -.
DR   OMA; RWQNEKF; -.
DR   OrthoDB; 1165385at2759; -.
DR   PhylomeDB; P11912; -.
DR   TreeFam; TF336032; -.
DR   PathwayCommons; P11912; -.
DR   Reactome; R-HSA-5690714; CD22 mediated BCR regulation.
DR   Reactome; R-HSA-983695; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers.
DR   SignaLink; P11912; -.
DR   SIGNOR; P11912; -.
DR   BioGRID-ORCS; 973; 23 hits in 1065 CRISPR screens.
DR   EvolutionaryTrace; P11912; -.
DR   GeneWiki; CD79A; -.
DR   GenomeRNAi; 973; -.
DR   Pharos; P11912; Tbio.
DR   PRO; PR:P11912; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; P11912; protein.
DR   Bgee; ENSG00000105369; Expressed in spleen and 140 other tissues.
DR   ExpressionAtlas; P11912; baseline and differential.
DR   Genevisible; P11912; HS.
DR   GO; GO:0019815; C:B cell receptor complex; ISS:UniProtKB.
DR   GO; GO:0009897; C:external side of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0045121; C:membrane raft; ISS:UniProtKB.
DR   GO; GO:0005771; C:multivesicular body; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0042802; F:identical protein binding; IDA:CAFA.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; IEA:InterPro.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0042113; P:B cell activation; ISS:UniProtKB.
DR   GO; GO:0030183; P:B cell differentiation; ISS:UniProtKB.
DR   GO; GO:0042100; P:B cell proliferation; ISS:UniProtKB.
DR   GO; GO:0050853; P:B cell receptor signaling pathway; ISS:UniProtKB.
DR   DisProt; DP01486; -.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR039695; CD79a/CD79b.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR013151; Immunoglobulin.
DR   InterPro; IPR003110; Phos_immunorcpt_sig_ITAM.
DR   PANTHER; PTHR14334; PTHR14334; 1.
DR   Pfam; PF00047; ig; 1.
DR   Pfam; PF02189; ITAM; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 1.
DR   SMART; SM00077; ITAM; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS51055; ITAM_1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Adaptive immunity; Alternative splicing; Cell membrane;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein; Immunity;
KW   Immunoglobulin domain; Membrane; Methylation; Phosphoprotein;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..32
FT                   /evidence="ECO:0000269|PubMed:7514267"
FT   CHAIN           33..226
FT                   /note="B-cell antigen receptor complex-associated protein
FT                   alpha chain"
FT                   /id="PRO_0000014558"
FT   TOPO_DOM        33..143
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        144..165
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        166..226
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          33..116
FT                   /note="Ig-like C2-type"
FT   DOMAIN          177..205
FT                   /note="ITAM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00379"
FT   SITE            210
FT                   /note="Required for binding to BLNK"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         188
FT                   /note="Phosphotyrosine; by SRC-type Tyr-kinases"
FT                   /evidence="ECO:0000250|UniProtKB:P11911,
FT                   ECO:0000255|PROSITE-ProRule:PRU00379"
FT   MOD_RES         199
FT                   /note="Phosphotyrosine; by SRC-type Tyr-kinases"
FT                   /evidence="ECO:0000250|UniProtKB:P11911,
FT                   ECO:0000255|PROSITE-ProRule:PRU00379"
FT   MOD_RES         204
FT                   /note="Asymmetric dimethylarginine; by PRMT1"
FT                   /evidence="ECO:0000250|UniProtKB:P11911"
FT   MOD_RES         210
FT                   /note="Phosphotyrosine; by Tyr-kinases"
FT                   /evidence="ECO:0000250|UniProtKB:P11911,
FT                   ECO:0000255|PROSITE-ProRule:PRU00379"
FT   CARBOHYD        57
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        63
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        73
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        88
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        97
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        112
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        54..106
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        119
FT                   /note="Interchain (with C-136 in beta chain)"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VAR_SEQ         89..127
FT                   /note="GTLIIQNVNKSHGGIYVCRVQEGNESYQQSCGTYLRVRQ -> E (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:7643857, ECO:0000303|Ref.9"
FT                   /id="VSP_002476"
FT   MUTAGEN         197
FT                   /note="S->A: Increased phosphorylation of Y-188; when
FT                   associated with A-203 and V-209."
FT                   /evidence="ECO:0000269|PubMed:10900006"
FT   MUTAGEN         203
FT                   /note="S->A: Increased phosphorylation of Y-188; when
FT                   associated with A-197 and V-209."
FT                   /evidence="ECO:0000269|PubMed:10900006"
FT   MUTAGEN         209
FT                   /note="T->V: Increased phosphorylation of Y-188; when
FT                   associated with A-197 and A-203."
FT                   /evidence="ECO:0000269|PubMed:10900006"
FT   CONFLICT        47
FT                   /note="G -> V (in Ref. 10; BAD97091)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        69
FT                   /note="V -> I (in Ref. 3; AAA60270)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        189
FT                   /note="E -> G (in Ref. 10; BAD97091)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   226 AA;  25038 MW;  6E5B837409969292 CRC64;
     MPGGPGVLQA LPATIFLLFL LSAVYLGPGC QALWMHKVPA SLMVSLGEDA HFQCPHNSSN
     NANVTWWRVL HGNYTWPPEF LGPGEDPNGT LIIQNVNKSH GGIYVCRVQE GNESYQQSCG
     TYLRVRQPPP RPFLDMGEGT KNRIITAEGI ILLFCAVVPG TLLLFRKRWQ NEKLGLDAGD
     EYEDENLYEG LNLDDCSMYE DISRGLQGTY QDVGSLNIGD VQLEKP
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024